Iressa 2nd Line Phase III Study in Japan

PHASE3CompletedINTERVENTIONAL
Enrollment

484

Participants

Timeline

Start Date

September 30, 2003

Study Completion Date

November 30, 2006

Conditions
Non-Small Cell Lung Cancer
Interventions
DRUG

Gefitinib or Docetaxel

Trial Locations (40)

Unknown

Research Site, Nagoya

Research Site, Okazaki

Research Site, Hirosaki

Research Site, Kashiwa

Research Site, Matsuyama

Research Site, Fukuoka

Research Site, Gifu

Research Site, Asahikawa

Research Site, Sapporo

Research Site, Akashi

Research Site, Kobe

Research Site, Naka-gun

Research Site, Isehara

Research Site, Sagamihara

Research Site, Yokohama

Research Site, Kumamoto

Research Site, Sendai

Research Site, Nagasaki

Research Site, Ōmura

Research Site, Niigata

Research Site, Beppu

Research Site, Okayama

Research Site, Habikino

Research Site, Izumisano

Research Site, Osaka

Research Site, Sakai

Research Site, Sayama

Research Site, Toyonaka

Research Site, Iwata

Research Site, Sunto-gun

Research Site, Bunkyo-ku

Research Site, Chūō

Research Site, Kiyose

Research Site, Minato-ku

Research Site, Shinjuku

Research Site, Sumida City

Research Site, Toshima-ku

Research Site, Yamagata

Research Site, Ube

Research Site, Kanazawa

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY